Articles from Galan Lithium Limited

HighlightsRamp-up of Hombre Muerto West (HMW) Phase 1 operations progressing well with first lithium chloride concentrate sales on track for Q4 CY 2026Over 3 months of plant operational data recorded with 98% or greater rejection of sulphate, supporting the upgrading of lithium chloride concentrate to the targeted 6% Li contentInitial targeted throughput rate of 4 ktpa LCE expected to be achieved in H1 2027 as the plant transitions into warmer seasonal conditionsEarthworks associated with the expansion of HMW Phase 1 from 4 ktpa to 5.2 ktpa LCE have commenced on site, with higher production volumes targeted in H2 2027Additional plant processing capacity planned to provide greater operational resiliency through future wintersStrong cash position of A$25 million with no debt. Undrawn offtake prepayment facility of US$ 6 million

HighlightsFirst LiCl concentrate sales on track: Galan remains on schedule to deliver first lithium chloride (LiCl) concentrate sales from HMW Phase 1 in Q4 CY2026.Impurity separation performing in line with expectations: The nanofiltration plant continues to deliver impurity separation in line with piloting results and Company expectations.Ramp-up productivity improving: Plant productivity has continued to improve throughout the ramp-up period, providing confidence the initial targeted throughput rate of 4ktpa will be achieved as the operation moves into warmer seasonal conditions. Additional plant processing capacity is planned for operational resilience in winter.Phase 1 expansion earthworks commenced: Earthworks associated with the initial expansion of HMW to 5.2 ktpa have commenced on site.

Galan Lithium Limited (ASX:GLN) (Galan or the Company) is pleased to release an updated investor presentation, highlighting the Company's position as an emerging ASX-listed lithium producer with a top-10 global lithium resource, trading at a material discount to its ASX-listed peers.

Highlights